Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trialChuanhua Zhao, Chuan Jin, Weiqing Chen et al.|Signal Transduction and Targeted Therapy|2025Cited by 20
Study of endometrial carcinoma on correlation between molecular typing and lymph node metastasis and construction of prediction model.Quanhong Jiang, Zhuang Li, Qiu-Yue Han et al.|Journal of Clinical Oncology|2023Cited by 0